Direkt zum Inhalt
Merck

GE17-5478-01

Capto L

Cytiva 17-5478-01, pack of 25 mL

Anmeldenzur Ansicht organisationsspezifischer und vertraglich vereinbarter Preise


About This Item

UNSPSC-Code:
41106500
NACRES:
NA.56

ligand

recombinant protein L (E. coli), mammalian free

Verpackung

pack of 25 mL

Hersteller/Markenname

Cytiva 17-5478-01

Lagerbedingungen

(20% Ehtanol)

Matrix

rigid, highly cross-linked agarose

Durchschnittliche Teilgröße

85 μm (d₅₀v is the median particle size of the cumulative volume distribution)

Arbeitsbereich

2-10(pH interval where the medium can be operated without significant change in function.)

Eignung

suitable for bioprocess medium

Lagertemp.

2-8°C

Allgemeine Beschreibung

Capto L resin is designed for antibody fragment purification, when the fragment contains the kappa light chain.

Affinity resin for antibody fragment purification

Capto L combines a rigid, high-flow agarose matrix with the immunoglobulin-binding recombinant protein L ligand, which has a strong affinity to the variable region of antibody kappa light chains. The high binding capacity and affinity to a broad range of antibody fragments makes this resin an excellent capture platform for antibody fragments containing kappa light chains. Common uses include domain antibody (dAb), scFv, and Fab purification.

Using this protein L resin

Capto L resin requires minimal optimization and produces high purity in one separation step, resulting in significant savings during process development. This resin is also advantageous in manufacturing, because high selectivity of affinity capture reduces the number of subsequent polishing steps.

Anwendung

Purification of antibody fragments using affinity chromatography

Leistungsmerkmale und Vorteile

  • Suitable for the capture of a wide range of antibody fragments such as Fabs, dAbs, and single-chain fragment variable (scFv) .
  • High binding capacity, low ligand leakage, and selectivity for a broad range of antibody fragments reduces process time and amount of resin.
  • Enables a platform approach to antibody fragment purification.
  • Excellent productivity, process economy, and process design flexibility due to rigid matrix.
  • Hydrophilic base matrix ensures low levels of non-specific binding and low levels of host cell-derived impurities in the elution pool.
  • Fulfills industrial demands for security of supply, robust performance, and regulatory support.

Lagerung und Haltbarkeit

Please be aware this product may be shipped 90 days before the expiration date. For more information on the batch specific expiration date, please contact technical service.

Hinweis zur Analyse

To view the Certificate of Analysis for this product, please visit www.cytiva.com.

Rechtliche Hinweise

Capto is a trademark of Cytiva

Piktogramme

Flame

Signalwort

Warning

H-Sätze

Lagerklassenschlüssel

3 - Flammable liquids


Hier finden Sie alle aktuellen Versionen:

Analysenzertifikate (COA)

Lot/Batch Number

Leider sind derzeit keine COAs für dieses Produkt online verfügbar.

Wenn Sie Hilfe benötigen, wenden Sie sich bitte an Kundensupport

Besitzen Sie dieses Produkt bereits?

In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.

Die Dokumentenbibliothek aufrufen

Kunden haben sich ebenfalls angesehen

Protokolle

This page shows how to purify antibody fragments by affinity chromatography using Capto L products from GE Healthcare.

Unser Team von Wissenschaftlern verfügt über Erfahrung in allen Forschungsbereichen einschließlich Life Science, Materialwissenschaften, chemischer Synthese, Chromatographie, Analytik und vielen mehr..

Setzen Sie sich mit dem technischen Dienst in Verbindung.